Rick has over 25 years of demonstrated effectiveness creating and managing business operations worldwide from early phase to large cap. He has had leadership positions in multiple therapeutic areas, including, interventional neuroradiology, cardiology, peripheral vascular and digital health. Rick’s experience has caused and managed above market scalable growth at companies such as Boston Scientific, ev3, Covidien and Viz.ai.
